Developing a range of products to modify the human
microbiome and bring specific health benefits

OptiBiotix Health Plc is a life sciences company operating in one of the most progressive areas of biotechnological research - the modulation of the Human Microbiome.

Facts at a Glance

Three core technology platforms, with diversification into skin in 2016

CEO: Stephen O'Hara

Development programmes:

OptiScreen®: The identification and development of microbial strains (probiotics) which can effect human metabolism and physiology to create a health benefit (e.g. cholesterol, hypertension reduction, diabetes)

OptiBiotix®: The development of microbiome modulators which enhance the growth, biological activity, and biological effect of specific microbial genera and species creating the potential for targeted modulation of the human microbiome

SweetBiotix®: The development of sweet natural healthy sugars not digested in the human gut and hence calorie free

SkinBiotix ®: The development of microbial lysates and proteins which improve skin smoothness, remove pathogens, and promote wound healing